| Financial Year |
March 31 2023 |
| Monetary Funds |
1,230,583,244.58 |
| Held-for-trading Financial Assets |
10,000,000.00 |
| Notes Receivable |
17,919,456.06 |
| Accounts Receivable |
102,596,171.27 |
| Advances to Suppliers |
1,900,184.88 |
| Other Receivables |
3,148,363.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
155,522,576.41 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,511,780.62 |
| Total Current Assets |
1,536,426,411.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
213,718,063.02 |
| Under-construction Projects |
57,217,168.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
63,913,985.08 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,759,654.08 |
| Deferred Income Tax Assets |
2,193,095.14 |
| Other Non-Current Assets |
19,476,951.24 |
| Sub-Total of Non-Current Assets |
364,367,298.85 |
| Total Assets |
1,900,793,709.98 |
| Short-Term Loans |
429,170,039.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,431,220.00 |
| Accounts Payable |
141,899,684.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,605,363.64 |
| Taxes Payable |
5,980,231.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
433,170.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,829,883.62 |
| Other Current Liabilities |
13,703,524.40 |
| Sub-Total of Current Liabilities |
619,267,237.04 |
| Long-term Loans |
45,041,363.01 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,103,331.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
46,259,764.19 |
| Total Liabilities |
665,527,001.23 |
| Paid-In Capital(Or Share Stock) |
120,000,000.00 |
| Capital Surplus |
762,299,135.80 |
| Surplus Reserve |
43,637,496.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
309,330,182.19 |
| Minority Stockholder's Interest |
-105.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,235,266,814.52 |
| Owner's Equity（Stockholder's Equity） |
1,235,266,708.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,900,793,709.98 |
